Northern Trust
TELO icon

Northern Trust’s Telomir Pharmaceuticals TELO Stock Holding History

Northern Trust’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.8K Buy
61,532
+19,688
+47% +$25.6K ﹤0.01% 4179
2026
Q1 		$54.4K Hold
41,844
– – ﹤0.01% 4230
2025
Q4 		$55.7K Hold
41,844
– – ﹤0.01% 4262
2025
Q3 		$58.2K Hold
41,844
– – ﹤0.01% 4258
2025
Q2 		$52.3K Sell
41,844
-112,228
-73% -$259K ﹤0.01% 4225
2025
Q1 		$498K Buy
154,072
+2,444
+2% +$10.7K ﹤0.01% 3581
2024
Q4 		$625K Buy
151,628
+102,948
+211% +$485K ﹤0.01% 3577
2024
Q3 		$313K Buy
+48,680
New +$237K ﹤0.01% 3720

Other funds holding TELO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.04B AUM 22.7% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return

Northern Trust's TELO Position: Q2 2026 in Review

Northern Trust increased its Telomir Pharmaceuticals (TELO) stake by 47% in Q2 2026, buying an estimated $25.6K and bringing the position to 61,532 shares worth $78.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4179.

Northern Trust first reported a position in TELO in Q3 2024 and has held it in 8 quarters since. The position peaked at $625K in Q4 2024. 33 funds tracked by Wall St. Rank hold TELO as of Q2 2026.

  • Northern Trust held 61,532 shares of Telomir Pharmaceuticals worth $78.8K as of Q2 2026.
  • Northern Trust bought 19,688 Telomir Pharmaceuticals shares in Q2 2026, an estimated $25.6K.
  • Telomir Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4179 holding.
  • Northern Trust first reported a position in Telomir Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Northern Trust's Telomir Pharmaceuticals position peaked at $625K in Q4 2024.
  • 33 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.